|Please Do NOT submit your manuscripts to this OLD website. We only review articles on the new Journal Website: www.brief.land/ijpr|
Our new website is launched! Visit our new website at https://brief.land/ijpr/
We are pleased to announce that from 1 Jan 2022, the Iranian Journal of Pharmaceutical Research (IJPR) is being published with our new publisher: Briefland!
The editorial board of the journal is pleased to announce that, beginning with volume 21 (1 Jan 2022 ), IJPR is being published by Briefland. The attention of the readers and reviewers of this journal is called to this important change since all processes of submission, tracking, and publishing should be henceforth to the new publisher Briefland.
Concomitant with the change in publisher is an increase in the overall dimensions of the journal environment. Authors are requested to refer to the revised “instruction for Authors”, especially concerning the new regulations of article acceptance charge.
Date of Change
|Till 31 Dec 2021||From 1 Jan 2022 to present|
|Scope||No change||No change|
|Issues||Till Volume 20 (end of 2021)||From Volume 21 (1 Jan 2022)|
|Article Acceptance fee||Refer Here!|
|Instruction for Authors||Refer Here!|
We look forward to hearing you about our new website.
Abstracting and Indexing:
PubMed / Chemical Abstracts / Index Copernicus / IMEMR / DOAJ / Biosis Previews / ISI Web of Science (Science Citation Index Expanded) / Journal Citation Reports / IPA / EMBASE / Scopus / EMR medex / EMRO / Iran medex / Open J-Gate / Scientific Information Database (SID) / EBSCO / ISC / Iran Journal / Google Scholar
Impact Factor (2020): 1.696
5-Year Journal Impact Factor: 1.998